Test Price
2,800 AED✅ Home Collection Available
VPS37A Gene SPG53 Genetic Test – Dubai, UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
🔬 Executive Clinical Summary
- Accuracy Guarantee: 99.9% diagnostic sensitivity for VPS37A pathogenic variants via ISO 9001:2015 accredited NGS processing.
- Premium Logistics: Hospital-grade home collection with certified cold‑chain transport (8 AM–11 PM). VIP mobile phlebotomy included.
- Clinical Guidance: Telephonic post‑test clinical interpretation session with a DHA‑licensed consultant medical geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731 – most UAE policies accepted.
Core Metrics: Price: 2,800 AED (all‑inclusive) | TAT: 3–4 weeks | Methodology: Whole‑exon NGS with CNV detection | DHA License: 1143
Test Overview & Methodology
The VPS37A Gene SPG53 Genetic Test is a definitive molecular diagnostic tool that identifies pathogenic variants in the VPS37A gene, confirming hereditary spastic paraplegia type 53 (SPG53)—a rare autosomal recessive neurological disorder. This test is essential for accurate diagnosis, family risk assessment, and guiding targeted management under DHA genetic testing standards.
Next‑Generation Sequencing (NGS) of the entire coding region plus exon‑level copy number variant (CNV) analysis is performed on an Illumina platform. Bioinformatic pipelines align reads to GRCh38, and all clinically significant variants are confirmed by Sanger capillary electrophoresis. The assay achieves >99.5% analytical sensitivity for single‑nucleotide variants, insertions, deletions, and CNVs in VPS37A.
| Feature | Our Premium Test | Closest Alternative (Standard) |
|---|---|---|
| Analytical Precision | 99.9% sensitivity Illumina NGS + full CNV calling |
~95% sensitivity, Sanger‑based hotspot testing only |
| Methodology | Next‑Generation Sequencing (whole coding region) | Single exon sequencing / limited panel |
| Turnaround Time | 3–4 Weeks with same‑day logistics | 5–8 Weeks from international labs |
Physician Insight & Safety Protocols
“A positive VPS37A mutation confirms SPG53, but clinical correlation with neurological examination and family history remains essential. Genetic results should never be viewed in isolation; they must be interpreted alongside your comprehensive clinical picture. I encourage every patient to undergo formal genetic counselling before and after testing to ensure emotional readiness and accurate understanding of carrier risks and reproductive options.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory – Do Not Self‑Adjust Therapy
Never discontinue or modify prescribed anti‑spasticity medications (baclofen, tizanidine, gabapentin) or other neurological treatments based solely on genetic findings. Abrupt withdrawal can precipitate severe rebound spasticity, autonomic instability, or seizure exacerbation. Always consult your treating neurologist before making any therapeutic changes.
Exclusion Criteria & Emergency Red Flags
- Unaccompanied minors: Genetic testing for individuals under 18 requires written parental consent and mandatory pre‑test genetic counselling per DHA guidelines.
- Rapidly progressive symptoms: Sudden loss of ambulation, new‑onset dysphagia, or respiratory muscle weakness – seek emergency neurological evaluation before pursuing elective genetic testing.
- Acute psychiatric crisis: Patients with active suicidal ideation or severe anxiety precipitated by genetic uncertainty should stabilise first.
- Pregnancy without counselling: Prenatal testing for VPS37A is restricted and must follow DHA‑approved prenatal diagnosis protocols.
Patient FAQ & Clinical Guidance
1. Why is the VPS37A NGS test the gold standard for SPG53 diagnosis in Dubai?
The VPS37A gene SPG53 NGS delivers a definitive molecular confirmation by sequencing the entire coding region with CNV detection, achieving over 99.5% analytical sensitivity—far exceeding single‑gene Sanger approaches. It aligns with DHA genetic testing regulations and is interpreted by a board‑certified consultant medical geneticist, ensuring your result is clinically actionable for treatment and family planning.
2. How is the sample collected and can it be done at home?
A standard peripheral blood draw or FTA card finger‑prick sample is used. Our VIP Mobile Phlebotomy service sends a DHA‑licensed phlebotomist to your home between 8 AM and 11 PM daily. Samples are transported under temperature‑controlled cold‑chain conditions compliant with ISO 9001:2015 standards.
3. What does the 2,800 AED price include, and will my insurance cover it?
Your 2,800 AED investment covers full NGS sequencing, clinical genetic counselling session, VIP home phlebotomy, and a comprehensive medical report. We verify insurance coverage directly via WhatsApp (+971 54 548 8731); most major UAE policies reimburse medically necessary genetic testing when pre‑authorised.
4. How long does it take to get results, and how will I receive them?
The standard turnaround time is 3–4 weeks from sample receipt in the laboratory. Results are delivered via a secure digital portal and discussed during a follow‑up telephonic consultation with the reporting consultant medical geneticist. A printed copy is also provided upon request.
UAE Regulatory & Data Privacy Adherence
🔒 Data Protection & Legal Compliance
DNA Labs UAE fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted at rest and in transit, access‑controlled, and never shared with third parties without explicit patient consent. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
The laboratory holds DHA Facility License Number 1143 and ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). Our operations are subject to periodic audit by the Dubai Health Authority and the UAE Ministry of Health & Prevention.
Clinical & Logistical Metadata
| Test Name | VPS37A Gene SPG53 Genetic Test (NGS) |
| Price (AED) | 2,800 AED (all‑inclusive) |
| Turnaround Time | 3–4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or FTA card finger‑prick. VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM–11 PM. |
| Methodology Used | Next‑Generation Sequencing (Illumina platform) with full CNV analysis; confirmatory Sanger sequencing for all clinically significant variants. |
| ICD-10-CM Code | G11.4 (Hereditary spastic paraplegia), G11.9 (Hereditary ataxia, unspecified) |
| LOINC Code | 21636-6 (DNA sequencing, targeted gene analysis) |
| DHA Facility License & Laboratory Address Invariants | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians